Search Within

Vivian Strong

Refine Results
Formats
  1. Journal Article (110)
  2. Meeting Abstract (33)
  3. Book Section (3)
  4. Book Whole (1)
  5. Conference Paper (1)
Groups
  1. Surgery (148)
  2. Gastrointestinal Disease Management Team (112)
  3. Soft Tissue Sarcoma Disease Management Team (112)
  4. Hepatopancreaticobiliary Disease Management Team (67)
  5. Melanoma Disease Management Team (60)
  6. Molecular Pharmacology and Chemistry Program Faculty (55)

More Groups

People
  1. Daniel Coit (68)
  2. Murray Brennan (49)
  3. Laura Tang (26)
  4. Mithat Gonen (26)
  5. David Ilson (21)
  6. Yelena Janjigian (19)

More People

Years
  1. 2019 (5)
  2. 2018 (14)
  3. 2017 (13)
  4. 2016 (16)
  5. 2015 (17)
  6. 2014 (15)

More Years

Publications
  1. Annals of Surgical Oncology (43)
  2. Journal of Clinical Oncology (13)
  3. Journal of Surgical Oncology (13)
  4. Journal of the National Comprehensive Cancer Network (8)
  5. Annals of Surgery (7)
  6. Journal of the American College of Surgeons (7)

More Publications

Publishers
  1. Springer (58)
  2. Wiley Blackwell (14)
  3. American Society of Clinical Oncology (13)
  4. Elsevier Inc. (10)
  5. Elsevier Science, Inc. (8)
  6. Harborside Press (8)

More Publishers

Results (148)

Export to EndNote | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 3 study of chemotherapy + pembrolizumab vs chemotherapy + placebo as neoadjuvant/adjuvant treatment for patients with gastric or gastroesophageal junction (G/GEJ) cancer: KEYNOTE-585 - Trial in progress
    Meeting Abstract

    Bang, Y.; Van Cutsem, E.; Fuchs, C.; Ohtsu, A.; Tabernero, J.; Ilson, D.; Hyung, W.; Strong, V.; Goetze, T.; Yoshikawa, T.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Progress in gastric cancer
    Journal Article

    Strong, V. E.
    Updates in Surgery (2018)

    Fulltext@MSK | Save
  • Rates of TP53 mutation are significantly elevated in African American patients with gastric cancer
    Journal Article

    van Beek, E. J. A. H.; Hernandez, J. M.; Goldman, D. A.; Davis, J. L.; McLaughlin, K.; Ripley, R. T.; Kim, T. S.; Tang, L. H.; Hechtman, J. F.; Zheng, J.; more...
    Annals of Surgical Oncology (2018)

    Fulltext@MSK | Save
  • Copy number gains in HER2 and VEGFα may predict poor outcome in early gastric cancer
    Meeting Abstract

    Russo, A. E.; Da Silva, E. M.; Kandoth, C.; Hernandez, J. M.; Van Beek, E.; Taylor, B. S.; Janjigian, Y. Y.; Tang, L. H.; Solit, D.; Strong, V. E.
    Annals of Surgical Oncology (2018)

    Fulltext@MSK | Save
  • TERT copy number alterations, promoter mutations and rearrangements in adrenocortical carcinomas: Clinico-pathologic and molecular analysis of 62 cases
    Meeting Abstract

    Gupta, S.; Won, H. H.; Nanjangud, G. J.; Chen, Y. B.; Al-Ahmadie, H.; Sirintrapun, S. J.; Fine, S. W.; Strong, V.; Raj, N. P.; Reidy, D. L.; more...
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • Risk of surgical site infection (SSI) following colorectal resection is higher in patients with disseminated cancer: An NCCN member cohort study
    Journal Article

    Kamboj, M.; Childers, T.; Sugalski, J.; Antonelli, D.; Bingener-Casey, J.; Cannon, J.; Cluff, K.; Davis, K. A.; Dellinger, E. P.; Dowdy, S. C.; more...
    Infection Control and Hospital Epidemiology (2018)

    Fulltext@MSK | Save
  • Post-treatment/pre-operative PET response is not an independent predictor of outcomes for patients with gastric and GEJ adenocarcinoma
    Journal Article

    Hernandez, J. M.; Beylergil, V.; Goldman, D. A.; van Beek, E.; Gonen, M.; Tang, L.; Downey, R.; Rizk, N.; Shah, M.; Strong, V.; more...
    Annals of Surgery (2018)

    Fulltext@MSK | Save
  • Genetic predictors of response to systemic therapy in esophagogastric cancer
    Journal Article

    Janjigian, Y. Y.; Sanchez-Vega, F.; Jonsson, P.; Chatila, W. K.; Hechtman, J. F.; Ku, G. Y.; Riches, J. C.; Tuvy, Y.; Kundra, R.; Bouvier, N.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save
  • Lauren histologic type is the most important factor associated with pattern of recurrence following resection of gastric adenocarcinoma
    Journal Article

    Lee, J. H.; Chang, K. K.; Yoon, C.; Tang, L. H.; Strong, V. E.; Yoon, S. S.
    Annals of Surgery (2018)

    Fulltext@MSK | Save
  • KEYNOTE-585: Randomized, phase 3 study of chemotherapy + pembrolizumab vs chemotherapy + placebo as neoadjuvant/adjuvant treatment for patients with gastric or gastroesophageal junction (G/GEJ) cancer
    Meeting Abstract

    Bang, Y. J.; Van Cutsem, E.; Fuchs, C.; Ohtsu, A.; Tabernero, J.; Ilson, D.; Hyung, W. J.; Strong, V.; Goetze, T.; Yoshikawa, T.; more...
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save